Press Releases Eastgate Biotech Corp.

Equities

ETBI

US2772531008

Market Closed - OTC Markets Other stock markets 07:51:18 07/06/2024 pm IST			5-day change	1st Jan Change
0.0045 ^USD	0.00%		-50.00%	-55.00%

2021	EastGate Biotech Corp., Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc. Enter Into a 3-way International Distribution Agreement	CI
2021	EastGate Biotech Corp. Enters into A Licensing and Distribution Agreement for Glucora	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

EastGate Biotech Corp. Enters Into a 3-way International Distribution Agreement With Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.	17/21/17	GL
EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets	08/21/08	GL
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19	18/20/18	GL
EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement	05/20/05	NE
EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus	30/20/30	GL
EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights	30/19/30	GL
EastGate Biotech Expands Pipeline to Alzheimer’s Disease Using its Alternative Insulin Delivery Platform	14/19/14	GL
EastGate Biotech Announces Expansion and Restructuring of Joint Venture with its Partner in Pakistan	09/19/09	GL
EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution	25/19/25	GL
EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer	04/19/04	GL
EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin	26/19/26	GL
Bill Abajian of EastGate Biotech Corp. to Speak at the 2019 M&A Forum for Pharma, Biotech, and Med Device to be Held Between August 12–14, 2019 in Philadelphia	12/19/12	GL
EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes	24/19/24	GL
EastGate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply	19/19/19	GL
EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships	30/19/30	GL
EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019	19/18/19	GL
EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market	03/18/03	NE
EastGate Biotech Corp., CEO Anna Gluskin and President, Rose Perri Visit Uptick Newswire’s “Stock Day” with Everett Jolly	29/18/29	GL
Eastgate Biotech Corp., Engages Gunpowder Capital Corp.	25/17/25	NE
Eastgate Biotech Featured on Uptick Newswire	11/16/11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Eastgate Biotech Corp.

Equities

ETBI

US2772531008

Press Releases

Filters